These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9443926

  • 1. Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways.
    Nishizaki T, Matsuoka T, Nomura T, Sumikawa K, Shiotani T, Watabe S, Yoshii M.
    Mol Pharmacol; 1998 Jan; 53(1):1-5. PubMed ID: 9443926
    [Abstract] [Full Text] [Related]

  • 2. [Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways].
    Yoshii M, Nishizaki T, Watabe S.
    Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():41P-43P. PubMed ID: 10190131
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam.
    Oyaizu M, Narahashi T.
    Brain Res; 1999 Mar 20; 822(1-2):72-9. PubMed ID: 10082885
    [Abstract] [Full Text] [Related]

  • 4. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
    Zhao X, Kuryatov A, Lindstrom JM, Yeh JZ, Narahashi T.
    Mol Pharmacol; 2001 Apr 20; 59(4):674-83. PubMed ID: 11259610
    [Abstract] [Full Text] [Related]

  • 5. Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission.
    Nishizaki T, Matsuoka T, Nomura T, Kondoh T, Watabe S, Shiotani T, Yoshii M.
    Alzheimer Dis Assoc Disord; 2000 Apr 20; 14 Suppl 1():S82-94. PubMed ID: 10850735
    [Abstract] [Full Text] [Related]

  • 6. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
    Nomura T, Nishizaki T.
    Brain Res; 2000 Jul 07; 870(1-2):157-62. PubMed ID: 10869513
    [Abstract] [Full Text] [Related]

  • 7. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors.
    Zhao X, Yeh JZ, Narahashi T.
    Ann N Y Acad Sci; 2001 Jun 07; 939():179-86. PubMed ID: 11462769
    [Abstract] [Full Text] [Related]

  • 8. Arachidonic acid potentiates ACh receptor currents by protein kinase C activation but not by receptor phosphorylation.
    Ikeuchi Y, Nishizaki T, Matsuoka T, Sumikawa K.
    Biochem Biophys Res Commun; 1996 Apr 25; 221(3):716-21. PubMed ID: 8630027
    [Abstract] [Full Text] [Related]

  • 9. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels.
    Yoshii M, Watabe S, Murashima YL, Nukada T, Shiotani T.
    Alzheimer Dis Assoc Disord; 2000 Apr 25; 14 Suppl 1():S95-102. PubMed ID: 10850736
    [Abstract] [Full Text] [Related]

  • 10. Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C.
    Nishizaki T, Sumikawa K.
    Brain Res Mol Brain Res; 1997 Oct 15; 50(1-2):121-6. PubMed ID: 9406926
    [Abstract] [Full Text] [Related]

  • 11. Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons.
    Huang CS, Ma JY, Marszalec W, Narahashi T.
    Neuropharmacology; 1996 Oct 15; 35(9-10):1251-61. PubMed ID: 9014140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of ACh receptor currents by arachidonic acid.
    Nishizaki T, Matsuoka T, Nomura T, Sumikawa K.
    Brain Res Mol Brain Res; 1998 Jun 01; 57(1):173-9. PubMed ID: 9630614
    [Abstract] [Full Text] [Related]

  • 14. Short-term depression and long-term enhancement of ACh-gated channel currents induced by linoleic and linolenic acid.
    Nishizaki T, Ikeuchi Y, Matsuoka T, Sumikawa K.
    Brain Res; 1997 Mar 21; 751(2):253-8. PubMed ID: 9099812
    [Abstract] [Full Text] [Related]

  • 15. Effects of PKC and PKA phosphorylation on desensitization of nicotinic acetylcholine receptors.
    Nishizaki T, Sumikawa K.
    Brain Res; 1998 Nov 23; 812(1-2):242-5. PubMed ID: 9813350
    [Abstract] [Full Text] [Related]

  • 16. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.
    Moriguchi S, Shioda N, Maejima H, Zhao X, Marszalec W, Yeh JZ, Fukunaga K, Narahashi T.
    Mol Pharmacol; 2007 Feb 23; 71(2):580-7. PubMed ID: 17095583
    [Abstract] [Full Text] [Related]

  • 17. The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors.
    Nishizaki T, Nomura T, Matuoka T, Kondoh T, Enikolopov G, Sumikawa K, Watabe S, Shiotani T, Yoshii M.
    Brain Res Mol Brain Res; 2000 Aug 14; 80(1):53-62. PubMed ID: 11039729
    [Abstract] [Full Text] [Related]

  • 18. Heterologous facilitation of G protein-activated K(+) channels by beta-adrenergic stimulation via cAMP-dependent protein kinase.
    Müllner C, Vorobiov D, Bera AK, Uezono Y, Yakubovich D, Frohnwieser-Steinecker B, Dascal N, Schreibmayer W.
    J Gen Physiol; 2000 May 14; 115(5):547-58. PubMed ID: 10779313
    [Abstract] [Full Text] [Related]

  • 19. A serum factor potentiates ACh and AMPA receptor currents via differential signal transduction pathways.
    Nishizaki T, Matsuoka T, Nomura T, Sumikawa K.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):565-8. PubMed ID: 9299552
    [Abstract] [Full Text] [Related]

  • 20. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
    Texidó L, Ros E, Martín-Satué M, López S, Aleu J, Marsal J, Solsona C.
    Br J Pharmacol; 2005 Jul 18; 145(5):672-8. PubMed ID: 15834443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.